Resistance to the auxin-like herbicide picloram has been reported in a yellow starthistle population growing in Washington. In addition, this population is cross resistant to clopyralid, another auxin-like herbicide. To understand the mechanism of resistance to clopyralid, studies were was conducted to determine uptake and translocation and to characterize clopyralid-induced ethylene production in the susceptible (S) and resistant (R) biotypes. R and S yellow starthistle plants were grown under ambient greenhouse conditions until full rosette stage and then transferred to a growth chamber (14-hour photoperiod, 25°C, 200 mol·m–2·s–1) 48 hours before treatment. Radiolabel solutions were prepared from 12C and 14C-clopyralid. Each treatment in the uptake experiment contained 0.009 Ci (20,000 dpm) and in the translocation experiment 0.225 Ci (500,000 dpm). Clopyralid 11.7 mm (420 g a.e./ha) solutions were applied as six 0.5-L droplets to the adaxial surface of completely expanded leaves using a microsyringe. Radioactivity was quantified by Liquid Scintillation Spectrometry. Uptake was determined at specified times after treatment. Almost all clopyralid uptake occurred within the first 2 hours, with no significant differences between the two biotypes. The amount of picloram translocated was 2.4%, 40.2%, and 50.7% of that absorbed at 2, 24, and 96 hours after treatment, respectively, but was not different between biotypes. Clopyralid induced about ten times greater ethylene production in S than in R. Ethylene production was followed by epinasty and chlorosis but appears to play only a small role in the resistance mechanism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.